Anthony Tuesca AstraZeneca

Anthony Tuesca is a Director, Device Development within Biopharmaceutical Development at AstraZeneca. He has over 16 years of industry experience focused on Drug Product formulation and drug delivery and has worked on over 25 different biopharmaceutical programs in early and late stage clinical development and contributed to the approval and commercialization of five biologics products including Fasenra, Imfinzi, Wainua, Lumoxiti, Blincyto, Adtralza, and Saphnelo. His experience includes work on mAbs, enzymes, ADCs, bispecifics antibodies, fusion proteins, mRNA, oligonucleotides, peptides, hormones, and small molecules. Anthony earned his Ph.D. from Drexel University in Chemical and Biological Engineering and his B.S. in Chemical Engineering from Northwestern University.